Rabbit Recombinant Monoclonal SH3PX1/SNX9 antibody. Carrier free. Suitable for IHC-P, IP, WB, Flow Cyt (Intra), ICC/IF and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: PBS
IHC-P | IP | WB | Flow Cyt (Intra) | ICC/IF | |
---|---|---|---|---|---|
Human | Tested | Tested | Tested | Tested | Tested |
Mouse | Expected | Expected | Expected | Expected | Expected |
Rat | Predicted | Predicted | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Promotes internalization of TNFR. Promotes degradation of EGFR after EGF signaling. Stimulates the GTPase activity of DNM1. Promotes DNM1 oligomerization. Promotes activation of the Arp2/3 complex by WASL, and thereby plays a role in the reorganization of the F-actin cytoskeleton. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Has lower affinity for membranes enriched in phosphatidylinositol 3-phosphate.
SH3PX1, SH3PXD3A, SNX9, Sorting nexin-9, SH3 and PX domain-containing protein 1, SH3 and PX domain-containing protein 3A, Protein SDP1
Rabbit Recombinant Monoclonal SH3PX1/SNX9 antibody. Carrier free. Suitable for IHC-P, IP, WB, Flow Cyt (Intra), ICC/IF and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: PBS
ab250527 is the carrier-free version of Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
SH3PX1 also known as SNX9 is a protein with a mass of approximately 69 kDa. This protein contains an SH3 domain which enables it to bind to other proteins and participate in intracellular signaling pathways. SNX9 is widely expressed in various tissues including the brain and liver indicating a broad functional role in cellular processes. The expression of SNX9 in different cell types suggests its involvement in multiple cellular processes including membrane trafficking and cytoskeletal dynamics.
Functions of SNX9 extend to cellular endocytosis and membrane remodeling. It is part of the retromer complex which plays a role in sorting endosomal proteins back to the trans-Golgi network or plasma membrane. SNX9 facilitates the curvature of cellular membranes aiding the process of clathrin-mediated endocytosis. This protein's ability to bind with both phospholipids and cytoskeletal components highlights its importance in maintaining cellular architecture and facilitating signal transduction.
SNX9 integrates into the endocytic and signaling pathways. Its involvement in clathrin-mediated endocytosis and interactions with proteins like dynamin and WASP indicate its key role in vesicle formation and intracellular transport. SNX9 also participates within the Wnt signaling pathway functioning alongside proteins like LRP6 and GSK3 to mediate signal transduction processes that regulate cell fate determination. These pathways underline SNX9’s significance in processes controlling cellular growth and differentiation.
Alterations in SNX9 expression or function have associations with neurological disorders and cancer. SNX9 interactions with proteins like Cdc42 and cortactin highlight its relevance in brain development and its implications in schizophrenia. Abnormalities in SNX9-mediated endocytosis can disrupt cellular signaling leading to oncogenic transformation and contributing to the progression of cancers such as breast cancer. Understanding SNX9's role in these conditions may offer insights into potential therapeutic targets.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.Western blot analysis of HepG2 cell lysate immunoprecipitated using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 at 1/50 dilution. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate secondary antibody was used at 1/1000 dilution.
All lanes: Immunoprecipitation - Anti-SH3PX1/SNX9 antibody [EPR14399] (Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856)
Predicted band size: 67 kDa
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.
Lane 1: Wild-type HAP1 cell lysate (20 μg)
Lane 2: SH3PX1/SNX9 knockout HAP1 cell lysate (20 μg)
Lane 3: HeLa cell lysate (20 μg)
Lane 4: HCT116 cell lysate (20 μg)
Lanes 1 - 4: Merged signal (red and green). Green - Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 observed at 75 kDa. Red - loading control, Anti-GAPDH antibody [6C5] - Loading Control ab8245, observed at 37 kDa.
Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 was shown to specifically react with SH3PX1/SNX9 when SH3PX1/SNX9 knockout samples were used. Wild-type and SH3PX1/SNX9 knockout samples were subjected to SDS-PAGE. Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 and Anti-GAPDH antibody [6C5] - Loading Control ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-SH3PX1/SNX9 antibody [EPR14399] (Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856)
Predicted band size: 67 kDa
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HeLa cells labeling SH3PX1/SNX9 with Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 at 1/10 dilution (red) compared to a Rabbit IgG monoclonal isotype control (green), followed by Goat anti rabbit IgG (FITC) secondary antibody at 1/150 dilution.
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.Immunofluorescent analysis of 4% paraformaldehyde-fixed HCT-116 cells labeling SH3PX1/SNX9 with Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 at 1/100 dilution, followed by Goat anti rabbit IgG (Alexa Fluor®488) secondary antibody at 1/200 dilution. Counter stained with Dapi.
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.Immunofluorescent analysis of acetone-fixed HeLa cells labeling SH3PX1/SNX9 with Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 at 1/100 dilution, followed by Goat anti rabbit IgG (Alexa Fluor®488) secondary antibody at 1/200 dilution. Counter stained with Dapi.
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling SH3PX1/SNX9 with Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856 at 1/250 dilution, followed by prediluted HRP Polymer for Rabbit IgG. Counter stained with Hematoxylin. Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-SH3PX1/SNX9 antibody [EPR14399] (Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856) at 1/10000 dilution
All lanes: HCT-116 cell lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 67 kDa
Observed band size: 78 kDa
This data was developed using Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-SH3PX1/SNX9 antibody [EPR14399] (Anti-SH3PX1/SNX9 antibody [EPR14399] ab181856) at 1/50000 dilution
All lanes: HeLa cell lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 67 kDa
Observed band size: 78 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com